Status:
COMPLETED
Diagnostic of Lewy Body Dementia by Combining Scintigraphy (SPECT) Using a Specific Transporter and Magnetic Resonance Imaging (MRI)
Lead Sponsor:
University Hospital, Limoges
Conditions:
Lewy Body Dementia
Eligibility:
All Genders
65-90 years
Phase:
NA
Brief Summary
The aim of this study is to improve the diagnostic of Lewy body dementia by combining the scintigraphy (SPECT) usig a spécific transporter and magnetic resonance imaging (MRI).
Detailed Description
Lewy body dementia is the second leading cause of dementia in France after degenerative Alzheimer's disease. However its dignosis is difficult. Its comes in large part from the similarity of symptoms...
Eligibility Criteria
Inclusion
- Patients with alzheimer disease following NINCDS-ADRDA scale or Lewy body dementia following Mc Keith scale.
- Aged between 65 et 90 years
- Patients with visual hallucination
- Patients with helping people
- Patients with MMSE (Mini Mental State Examination) equal or more than 18.
- Signed consent
Exclusion
- Hospitalized patients without their consent
- Patients who have not passed the neuropsychological tests
- Patients with a MMSE less than 18
- Patients without helping
- Patients with no visual hallucinations
- Patients with severe somatic pathology.
- Pregnancy
- Allergy to iodine
Key Trial Info
Start Date :
March 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00820937
Start Date
March 1 2006
End Date
March 1 2008
Last Update
July 30 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Département de Gérontologie - Chu Limoges
Limoges, France, 87000
2
Pôle de psychiatrie du sujet âgé - CH Esquirol
Limoges, France, 87000
3
Service de Neurologie - CHU de Limoges
Limoges, France, 87000